Evidence map›Paper›PMID 41693975›Full record

Observational studyWorld journal of gastroenterology2026

Psychological and hematological factors associated with fatigue in patients with Crohn's disease receiving pharmacological treatment.

Tayane C Morais, Genalva Couto, Bruno César da Silva, Raísa A Lisbôa, Bruna S da Cruz, Maria G F Viana, Gabriela B C de Sousa, Lara P Arenas, Erick S Nery, Flora Maria Lorenzo Fortes and 7 more

Abstract readObservational Study
In one paragraph

Observational study in World journal of gastroenterology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Tayane C MoraisDepartment of Life Sciences, Postgraduate Program in Pharmaceutical Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Genalva CoutoDepartment of Life Sciences, Postgraduate Program in Pharmaceutical Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Bruno César da SilvaDivision of Gastroenterology, Hospital da Bahia, Salvador 41810-011, Bahia, Brazil.
Raísa A LisbôaDepartment of Life Sciences, Postgraduate Program in Pharmaceutical Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Bruna S da CruzDepartment of Life Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Maria G F VianaDepartment of Life Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Gabriela B C de SousaDepartment of Life Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Lara P ArenasDepartment of Life Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Erick S NeryDepartment of Life Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.
Flora Maria Lorenzo FortesOutpatient Inflammatory Bowel Disease Unit, Hospital Geral Roberto Santos, Salvador 41180-000, Bahia, Brazil.
Neogélia Pereira de AlmeidaOutpatient Inflammatory Bowel Disease Unit, Hospital Geral Roberto Santos, Salvador 41180-000, Bahia, Brazil.
Andréa Maia PimentelOutpatient Inflammatory Bowel Disease Unit, Hospital Geral Roberto Santos, Salvador 41180-000, Bahia, Brazil.
Jaciane Araújo Mota FontesOutpatient Inflammatory Bowel Disease Unit, Hospital Geral Roberto Santos, Salvador 41180-000, Bahia, Brazil.
Valdiana Cristina SurloOutpatient Inflammatory Bowel Disease Unit, Hospital Geral Roberto Santos, Salvador 41180-000, Bahia, Brazil.
Julio Fonseca ChebliInflammatory Bowel Diseases Center, Federal University of Juiz de Fora, Juiz de Fora 36036-900, Minas Gerais, Brazil.
Raquel RochaSchool of Nutrition, Federal University of Bahia, Salvador 40170-110, Bahia, Brazil. raquelrocha@ufba.br.
Genoile Oliveira SantanaDepartment of Life Sciences, Postgraduate Program in Pharmaceutical Sciences, Bahia State University, Salvador 41150-000, Bahia, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFatigue is debilitating and costly for patients with Crohn's disease (CD) and the healthcare system. Thus, as there are no well-established therapies for fatigue in patients with CD, it is essential to investigate its risk factors and collaborate to prevent or reduce its burden.

aimTo evaluate the variables associated with fatigue in outpatients with CD receiving pharmacological treatment.

methodsIt is an observational study. Data, including sociodemographic information, inflammatory bowel disease fatigue scores, visual analog scale scores, Depression Anxiety Stress Scale-21 scores, insomnia assessment results, and laboratory test results, were collected. Statistical analyses included Student's

resultsOne hundred patients were included (77% presented with fatigue). In the linear regression analysis, symptoms of depression, anxiety, stress, and insomnia were simultaneously included as predictors of fatigue. Although the model was statistically significant (adjusted

conclusionFatigue is associated with psychological symptoms, a sedentary lifestyle, and alterations in leukocyte subpopulations. Assessments incorporating composite symptom scales and hematological parameters may be practical and cost-effective for patients with fatigue.

Indexed as

Crohn DiseaseDepressionFatigueAdultAnxietyFemaleHumansLeukocyte CountMaleMiddle AgedRisk FactorsSeverity of Illness IndexSleep Initiation and Maintenance DisordersStress, PsychologicalYoung AdultAnemiaCrohn’s diseaseFatigueImmune systemInflammatory bowel diseaseInsomniaLeukocyte profile

Identifiers

PMID41693975
PMCPMC12897519

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.